Remission of Acromegaly: The Sooner the Better.
Clin Endocrinol (Oxf)
; 2024 Oct 07.
Article
em En
| MEDLINE
| ID: mdl-39373288
ABSTRACT
Remission of acromegaly is defined by normalization of GH/IGF-1 values according to age and gender. While treatment strategies, biochemical cut-off to reach, and morbidities related to the persistence of the disease are well described in the literature, there is little data focusing on the delay to reach remission and its consequences. In this commentary, the authors discussed the results obtained from the UK acromegaly registry showing that the time to biochemical remission predicts the overall survival of patients in acromegaly.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Clin Endocrinol (Oxf)
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
França